Human papillomavirus testing using HPV APTIMA® assay and an external cellularity control in self-collected samples.

Pasquier, Christophe; Raymond, Stéphanie; Duchanois, Delphine; Sauné, Karine; Oliveira-Mendes, Kevin; Vayssiere, Christophe; Izopet, Jacques

Pasquier, Christophe; Raymond, Stéphanie; Duchanois, Delphine; Sauné, Karine; Oliveira-Mendes, Kevin; Vayssiere, Christophe; Izopet, Jacques.

Pasquier C; Department of Virology, Toulouse University Hospital, Toulouse, France.
Raymond S; Department of Virology, Toulouse University Hospital, Toulouse, France.
Duchanois D; Research Unit in Obstetrics and Gynaecology (UROG), Toulouse University Hospital, Toulouse, France.
Sauné K; Department of Virology, Toulouse University Hospital, Toulouse, France.
Oliveira-Mendes K; Department of Virology, Toulouse University Hospital, Toulouse, France.
Vayssiere C; Research Unit in Obstetrics and Gynaecology (UROG), Toulouse University Hospital, Toulouse, France.
Izopet J; Department of Virology, Toulouse University Hospital, Toulouse, France.

J Med Virol ; 95(12): e29283, 2023 12.

Article en En | MEDLINE | ID: mdl-38088528

Asunto(s)

Infecciones por Papillomavirus; Displasia del Cuello del Útero; Neoplasias del Cuello Uterino; Femenino; Humanos; Neoplasias del Cuello Uterino/diagnóstico; Infecciones por Papillomavirus/diagnóstico; Sensibilidad y Especificidad; Frotis Vaginal/métodos; Detección Precoz del Cáncer/métodos; Papillomaviridae/genética; ARN Mensajero/genética; Manejo de Especímenes/métodos; Virus del Papiloma Humano

Palabras clave

HPV test; cellularity control; cervix cancer screening; high-risk papillomavirus; mRNA

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Displasia del Cuello del Útero / Neoplasias del Cuello Uterino / Infecciones por Papillomavirus Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google